New cancer clinical trial: Trial Comparing Niraparib-bevacizumab-TSR042 and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer

Published on: January 16, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share